Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Aug;12(4):327-34.
doi: 10.1007/s11920-010-0122-x.

Promise and pitfalls of animal models of schizophrenia

Affiliations
Review

Promise and pitfalls of animal models of schizophrenia

David Feifel et al. Curr Psychiatry Rep. 2010 Aug.

Abstract

Animal models are indispensible tools for advancing understanding of the cause of any given disease and developing new treatments. Developing animal models for schizophrenia presents formidable challenges owing to the distinctively human nature of the symptoms that define it and the thus-far-obscured underlying biological mechanisms. Nevertheless, progress has been and continues to be made in this important field of endeavor. This article discusses the challenges facing investigators who seek to develop and use animal models for translational research in schizophrenia and the responses that have emerged to those challenges, as well as the likely pathways that will lead to future progress.

PubMed Disclaimer

Similar articles

Cited by

References

    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4 (text revision) Washington, DC: American Psychiatric Association; 2000.
    1. Mouri A, Noda Y, Enomoto T, Nabeshima T. Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment. Neurochem Int. 2007;51:173–184. doi: 10.1016/j.neuint.2007.06.019. - DOI - PubMed
    1. Holmes PV. Rodent models of depression: reexamining validity without anthropomorphic inference. Crit Rev Neurobiol. 2003;15:143–174. doi: 10.1615/CritRevNeurobiol.v15.i2.30. - DOI - PubMed
    1. Geyer MA, Markou A. The role of preclinical models in the development of psychotropic drugs. In: Davis KL, Charney D, Coyle JT, Nemeroff CB, editors. Neuropsychopharmacology: The Fifth Generation of Progress. Washington, DC: American College of Neuropsychopharmacology; 2002. pp. 445–455.
    1. van der Staay FJ, Arndt SS, Nordquist RE. Evaluation of animal models of neurobehavioral disorders. Behav Brain Funct. 2009;5:11. doi: 10.1186/1744-9081-5-11. - DOI - PMC - PubMed

Publication types